Hangzhou Genesis Biodetection and Biocontrol Co., Ltd.

Founded in 2002 by President Dr. Gongxiang Chen, Hangzhou GENESIS Biodetection & Biocontrol Co., Ltd. (GENESIS Group) has been enjoying an renowned reputation for more than 20 years in the field of IVD (In Vitro Diagnostic Devices) in China and all over the world, including the US, European countries and Asia.

From the manufacturer's own website. Source

The company manufactures general specimen collection kits, including viral transport media such as saline and PBS solutions for extended viral transport, as well as rapid antigen tests for COVID-19. It also produces a COVID-19 neutralization antibody rapid test, a TB antigen detection device (MPT64), and a group B streptococcus (GBS) screening broth for microbiological use.

These devices are classified as Class A and Class I medical devices, with some designated as in vitro diagnostic (IVD) general devices and IVD self-testing products. They are listed in regulatory databases including EUDAMED, the FDA’s 510(k) and UDI registries, indicating compliance with European and US requirements. The company is based in China.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.